Departments

Departments

Back


Gastroenterological Surgery 2 Director：NAKAYAMA, Goro (Associate Professor)

Globally acclaimed for expertise in multidisciplinary approach and minimally invasive approach in all fields of gastrointestinal and hepatobiliary-pancreatic surgery

Multidisciplinary treatment with surgery at the core for neoplasms of the digestive system has been tailored for each patient and delivered with care.


Medical Care System

17 academic and 14 medical members provide outpatients and inpatients medical care. The outpatient clinic is open on Mondays, Tuesdays, Wednesdays, Thursdays, and Fridays, staffed by specialists in esophageal, gastric, colon, hepatobiliary pancreatic, endoscopic surgery, and metabolic surgery. For inpatients, professors and doctors collaborate to provide medical care as a team.

Target Diseases

Patients with neoplasms and other intractable disorders of the digestive system including esophagus, stomach, colon, rectum, pancreas, liver and biliary system are treated. This would include cancer of all stages, gastroesophageal reflux disease, achalasia, Crohn’s disease and ulcerative colitis. Laparoscopic and robotic approach has been selected where applicable.

Strong Fields

For esophageal, gastric, colon, and other digestive tract cancers, we take a minimally invasive approach like endoscopic and robotic surgery whenever possible, as well as pursuing radical cure. We are one of the world’s leading institutions in the combined resection of the pancreas and portal vein in pancreatic surgery using portal vein catheter bypass. A significant number of operations have been performed and it is now established as a safe procedure.

Clinical Results

The numbers of resections performed in 2021 are as follows: esophageal cancer: 60 (of those, 41 are open surgery, 19 are thoracoscopic surgery); gastric cancer: 48 (of those, 17 are open surgery, 17 are laparoscopic surgery, 14 are robotic surgery); colorectal cancer: 65 (of those, 12 are open surgery, 41 are laparoscopic surgery, 12 are robotic surgery); IBD: 54 (of those, 25 are open surgery, 29 are lapa-roscopic surgery); pancreatic disease: 70 (of those, 60 are open surgery, 10 are laparoscopic surgery); hepatectomy: 38 (of those, 27 are open surgery, 11 are laparoscopic surgery).

Advanced Medicine and Research

Our department actively conducts clinical studies on surgery and chemotherapy in the fields of gastric cancer, colorectal cancer, and pancreatic cancer at many facilities including hospitals affiliated to Nagoya University Hospital.